Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Tanaman obat Alor: Warisan tradisi lisan dan sains lokal

● Dokumentasi linguistik dan etnobotani dapat digunakan untuk melestarikan pengetahuan kuno tanaman obat di Kepulauan Alor-Pantar.● Tanaman bukan sekadar obat harian, melainkan elemen sakr...

Menghapus pilkada langsung: Mengamati pola berulang elite politik melawan kehendak rakyat

Poster warga dalam aksi menolak RUU Pilkada di Jakarta, Agustus 2024.(Donny Hery/Shutterstock)● Wacana pemilihan kepala daerah oleh DPRD kembali menguat sebagai pola berulang elite politik.χ...

‘Polyworking’: Ketika 1 pekerjaan tak lagi cukup

● Kenaikan harga kebutuhan setiap tahun memaksa banyak orang mencari pekerjaan tambahan.● Pekerjaan tambahan yang dimaksud tidak hanya sampingan, tapi dilakukan dengan intensitas yang hamp...